154 related articles for article (PubMed ID: 6131079)
21. Importance of glucagon in mediating epinephrine-induced hyperglycemia in alloxan-diabetic dogs.
Perez G; Kemmer FW; Lickley HL; Vranic M
Am J Physiol; 1981 Oct; 241(4):E328-35. PubMed ID: 7032319
[TBL] [Abstract][Full Text] [Related]
22. Role of insulin and glucagon in oxytocin effects on glucose metabolism.
Altszuler N; Winkler B; Rosenberg CR; Pi-Sunyer FX; Fuchs AR
Proc Soc Exp Biol Med; 1992 Feb; 199(2):236-42. PubMed ID: 1346936
[TBL] [Abstract][Full Text] [Related]
23. In vivo and in vitro effects of adenosine-5'-O-(2-thiodiphosphate) on pancreatic hormones in dogs.
Hillaire-Buys D; Gross R; Parés-Herbuté N; Ribes G; Loubatières-Mariani MM
Pancreas; 1994 Sep; 9(5):646-51. PubMed ID: 7809020
[TBL] [Abstract][Full Text] [Related]
24. Somatostatin secretion in diabetic rabbits.
Wilson HK; Boyd AE; Bolton WE; Conaway HH
Metabolism; 1982 May; 31(5):428-32. PubMed ID: 6123063
[TBL] [Abstract][Full Text] [Related]
25. Effect of bombesin upon plasma somatostatin-like immunoreactivity, insulin and glucagon in normal and chemically sympathectomized dogs.
Schusdziarra V; Rouiller D; Harris V; Pfeiffer EF; Unger RH
Regul Pept; 1980 Oct; 1(2):89-96. PubMed ID: 6114514
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
Berelowitz M; Kronheim S; Pimstone B; Shapiro B
J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
[TBL] [Abstract][Full Text] [Related]
27. The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.
Cherrington AD; Chiasson JL; Liljenquist JE; Jennings AS; Keller U; Lacy WW
J Clin Invest; 1976 Dec; 58(6):1407-18. PubMed ID: 993351
[TBL] [Abstract][Full Text] [Related]
28. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
Schusdziarra V; Zyznar E; Rouiller D; Harris V; Unger RH
Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
[TBL] [Abstract][Full Text] [Related]
29. Release of somatostatin-like immunoreactivity from the lower gut.
Rouiller D; Schusdziarra V; Conlon JM; Harris V; Unger RH
Gastroenterology; 1979 Oct; 77(4 Pt 1):700-3. PubMed ID: 467926
[TBL] [Abstract][Full Text] [Related]
30. Nonadrenergic sympathetic neural influences on basal pancreatic hormone secretion.
Dunning BE; Ahrén B; Veith RC; Taborsky GJ
Am J Physiol; 1988 Dec; 255(6 Pt 1):E785-92. PubMed ID: 2904765
[TBL] [Abstract][Full Text] [Related]
31. Role of histamine H2-receptors in gastric and pancreatic release of somatostatin-like immunoreactivity during the gastric phase of meal.
Schusdziarra V; Rouiller D; Harris V; Unger RH
Regul Pept; 1981 Feb; 1(5):353-63. PubMed ID: 7255767
[TBL] [Abstract][Full Text] [Related]
32. Suppressive effect of secretin upon pancreatic alpha cell function.
Santeusanio F; Faloona GR; Unger RH
J Clin Invest; 1972 Jul; 51(7):1743-9. PubMed ID: 4555784
[TBL] [Abstract][Full Text] [Related]
33. Galanin release during pancreatic nerve stimulation is sufficient to influence islet function.
Dunning BE; Taborsky GJ
Am J Physiol; 1989 Jan; 256(1 Pt 1):E191-8. PubMed ID: 2463765
[TBL] [Abstract][Full Text] [Related]
34. Calcitonin gene-related peptide: a potent and selective stimulator of gastrointestinal somatostatin secretion.
Dunning BE; Taborsky GJ
Endocrinology; 1987 May; 120(5):1774-81. PubMed ID: 2882997
[TBL] [Abstract][Full Text] [Related]
35. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 2). Effects on basal release of somatostatin and pancreatic polypeptide.
Ahrén B; Veith RC; Paquette TL; Taborsky GJ
Endocrinology; 1987 Jul; 121(1):332-9. PubMed ID: 2885175
[TBL] [Abstract][Full Text] [Related]
36. Plasma Somatostatin-like immunoreactivity in chemically sympathectomized dogs.
Schusdziarra V; Rouiller D; Harris V; Dey R; Unger RH
Horm Metab Res; 1980 Dec; 12(12):656-60. PubMed ID: 6110628
[TBL] [Abstract][Full Text] [Related]
37. Modulatory effect of glucose, amino acids, and secretin on CCK-8-induced somatostatin and pancreatic polypeptide release in dogs.
Schusdziarra V; Lenz N; Schick R; Maier V
Diabetes; 1986 May; 35(5):523-9. PubMed ID: 2869995
[TBL] [Abstract][Full Text] [Related]
38. Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.
Schusdziarra V; Lawecki J; Ditschuneit HH; Lukas B; Maier V; Pfeiffer EF
Diabetes; 1985 Jun; 34(6):595-601. PubMed ID: 2861127
[TBL] [Abstract][Full Text] [Related]
39. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
Lickley HL; Kemmer FW; Doi K; Vranic M
Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.
Saccà L; Cicala M; Trimarco B; Ungaro B; Vigorito C
J Clin Invest; 1982 Jul; 70(1):117-26. PubMed ID: 6123524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
